Pere Barba

13PUBLICATIONS

141CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyEpidemiological methodsPredictive and prognostic markersHaematological tumours

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (13)

Sort by Publication Date:

|Jun 04, 2026

CAR T-cell Kinetics, Persistence, and Clinical Outcomes in Adult Patients with Relapsed/Refractory B-cell ALL Treated with Obecabtagene Autoleucel in the FELIX Study.

|Mar 28, 2026

Correction: Pourroy et al. High-Dose Methotrexate at All Ages: Safety, Efficacy, and Outcomes from the HDMTX European Registry. <i>Cancers</i> 2026, <i>18</i>, 124.

Bertrand Pourroy, Maria D Aumente, Christian Koenecke

|Feb 14, 2026

CAR T-cell therapy in patients with acute lymphoblastic leukemia: a systematic review and meta-analysis.

Victor Navarro, Gloria Iacoboni, Sergi Camarillas

|Jan 10, 2026

High-Dose Methotrexate at All Ages: Safety, Efficacy, and Outcomes from the HDMTX European Registry.

Bertrand Pourroy, Maria D Aumente, Christian Koenecke

|Nov 13, 2025

The Potential of the Gut Microbiota and Butyrate to Enhance CAR T-cell Therapy in Non-Hodgkin Lymphoma.

Roberto García-Vicente, Alba Rodríguez-García, Raquel Ancos-Pintado

|Apr 24, 2024

Efficacy of CAR T-cell therapy is not impaired by previous bispecific antibody treatment in large B-cell lymphoma.

Gilles Crochet, Gloria Iacoboni, Audrey Couturier

Pageof 3

Frequent Collaborators

Gloria Iacoboni

Cecilia Carpio

Mi Kwon

Francesc Bosch

Guillermo Villacampa

José Luis Piñana

Rodrigo Martino

Víctor Navarro

David Valcarcel

Jorge Sierra

Frequent Collaborators

Gloria Iacoboni

Cecilia Carpio

Mi Kwon

Francesc Bosch